Directori de persones
Mariona Jove Font

Mariona Jove Font

Grau: Doctor/a

22 69
mariona.jove(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/M-9104-2016

Grups

Publicacions

  • Sol J; Obis È; Mota-Martorell N; Pradas I; Galo-Licona JD; Martin-Garí M; Fernández-Bernal A; Ortega-Bravo M; Mayneris-Perxachs J; Borrás C; Viña J; de la Fuente M; Mate I; Biarnes C; Pedraza S; Vilanova JC; Brugada R; Ramos R; Serena J; Ramió-Torrentà L; Pineda V; Daunis-I-Estadella P; Thió-Henestrosa S; Barretina J; Garre-Olmo J; Portero-Otin M; Fernández-Real JM; Puig J; Jové M; Pamplona R

    Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome.

    AGING CELL 22 -. .

    [doi:10.1111/acel.13821]

  • Pamplona, R; Jove, M; Gomez, J; Barja, G

    Programmed versus non-programmed evolution of aging. What is the evidence?

    Experimental Gerontology 175 112162-112162. .

    [doi:10.1016/j.exger.2023.112162]

  • Gómez J; Mota-Martorell N; Jové M; Pamplona R; Barja G

    Mitochondrial ROS production, oxidative stress and aging within and between species: Evidences and recent advances on this aging effector.

    Experimental Gerontology 174 112134-112134. .

    [doi:10.1016/j.exger.2023.112134]

  • Pamplona R; Jové M; Gómez J; Barja G

    Whole organism aging: Parabiosis, inflammaging, epigenetics, and peripheral and central aging clocks. The ARS of aging.

    Experimental Gerontology 174 112137-112137. .

    [doi:10.1016/j.exger.2023.112137]

  • Dakterzada, F; Jove, M; Huerto, R; Carnes, A; Sol, J; Pamplona, R; Piñol-Ripoll G

    Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer's Disease.

    Aging and Disease 14 1728-1738. .

    [doi:10.14336/AD.2023.0221]

  • Obis, E; Sol, J; Andres-Benito, P; Martin-Gari, M; Mota-Martorell, N; Galo-Licona, JD; Piñol-Ripoll G; Portero-Otin, M; Ferrer, I; Jove, M; Pamplona, R

    Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer's Disease.

    Aging and Disease 14 1887-1916. .

    [doi:10.14336/AD.2023.0217]

  • Jové M; Mota-Martorell N; Obis È; Sol J; Martín-Garí M; Ferrer I; Portero-Otin M; Pamplona R

    Ether Lipid-Mediated Antioxidant Defense in Alzheimer's Disease.

    Antioxidants 12 -. .

    [doi:10.3390/antiox12020293]

  • Jové M; Mota-Martorell N; Obis È; Sol J; Martín-Garí M; Ferrer I; Portero-Otín M; Pamplona R

    Lipid Adaptations against Oxidative Challenge in the Healthy Adult Human Brain.

    Antioxidants 12 -. .

    [doi:10.3390/antiox12010177]

  • Dakterzada F; Jové M; Cantero JL; Pamplona R; Piñoll-Ripoll G

    Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease.

    Redox Biology 64 102772-102772. .

    [doi:10.1016/j.redox.2023.102772]

  • Mota-Martorell N; Jové M; Berdún R; Òbis È; Barja G; Pamplona R

    Methionine Metabolism Is Down-Regulated in Heart of Long-Lived Mammals.

    Biology-Basel 11 -. .

    [doi:10.3390/biology11121821]

  • Sol, J; Colàs-Campàs L; Mauri-Capdevila, G; Molina-Seguin, J; Galo-Licona, JD; Torres-Querol, C; Aymerich, N; Ois, A; Roquer, J; Tur, S; García-Carreira MDC; Marti-Fabregas, J; Cruz-Culebras, A; Segura, T; Pamplona, R; Portero-Otin, M; Arque, G; Jove, M; Purroy, F

    Ischemia preconditioning induces an adaptive response that defines a circulating metabolomic signature in ischemic stroke patients.

    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 42 2201-2215. .

    [doi:10.1177/0271678X221116288]

  • Viña J; Escudero J; Baquero M; Cebrián M; Carbonell-Asíns JA; Muñoz JE; Satorres E; Meléndez JC; Ferrer-Rebolleda J; Cózar-Santiago MDP; Santabárbara-Gómez JM; Jové M; Pamplona R; Tarazona-Santabalbina FJ; Borrás C

    Genistein effect on cognition in prodromal Alzheimer's disease patients. The GENIAL clinical trial.

    Alzheimers Research & Therapy 14 164-164. .

    [doi:10.1186/s13195-022-01097-2]

Projectes

  • Mejorando la Comprensión de la Demencia a través de la Exploración de Registros Clínicos y Datos Omics
  • Development of dynamic models for the personalized prevention and treatment of age-related diseases
  • From GFAP mutations in astrocytes to neurodegeneration: exploring a lipid-protein oxidation pathway (ASTROMAD)
  • Dynamics of the neuronal, metabolomic and neuropsychological signatures underlying the adptations for motherhood during pregnancy. (babybrain)
  • Estrés celulares y alteraciones en los lipidomas neuronales, gliales y extracelulares en la fisiopatología de la esclerosis lateral amiotrófica.
  • "Imagenoma de l'Envelliment": Estudi observacional poblacional per definir biomarcadors d'imatge RM corporal integral i òmics que s'associen al procés d'envelliment i a factors de risc biopsicosocial en subjectes adults i que defineixen la seva trajectòria vital cap a un envelliment saludable o bé la fragilitat i discapacitat.
  • SYSTEMS BIOMEDICINE FOR UNRAVELLING THE MOLECULAR BASIS AND MODELLING CORTICOSPINAL MOTORNEURON DISEASE
  • Interactomas y marcadores para discriminar factores de vulnerabilidad neuronal regional en la neurodegeneración asociada al envejecimiento normal y patológico en el SNC
  • ESTRES CELULAR Y DESLOCALIZACION DE FACTORES TRANSCRIPCIONALES EN LA FISIOPATOLOGIA DE LA ELA
  • ESTRES OXIDATIVO E INFLAMACION EN LA EVOLUCION DEL PROCESO DE ENVEJECIMIENTO Y PROGRESION DE LA ENFERMEDAD DE ALZHEIMER EN DIFERENTES REGIONES DEL SISTEMA NERVIOSO CENTRAL HUMANO
  • MECANISMOS DE SENESCENCIA CELULAR BASADOS EN EL ESTRES OXIDATIVO EN LA PATOGENIA DE LA ESCLEROSIS LATERAL AMIOTROFICA
  • ENVEJECIMIENTO CELULAR COMO MECANISMO PATOGENICOEN ESCLEROSIS LATERAL AMIOTROFICA: RELACION ENTRE PEROXIDACION LIPIDICA, AUTOFAGIA Y BIOGENESIS MITOCONDRIAL